These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 18846059)

  • 1. Plasma product companies outmuscle small recombinant players.
    Mitchell P
    Nat Biotechnol; 2008 Oct; 26(10):1060-1. PubMed ID: 18846059
    [No Abstract]   [Full Text] [Related]  

  • 2. Chiron's manufacturing misfortunes boost competitors.
    Sheridan C
    Nat Biotechnol; 2005 Oct; 23(10):1191. PubMed ID: 16211043
    [No Abstract]   [Full Text] [Related]  

  • 3. Jordanian pharmaceutical companies: are their marketing efforts paying off?
    Al-Shaikh MS; Torres IM; Zuniga MA; Ghunaim A
    Health Mark Q; 2011 Apr; 28(2):174-89. PubMed ID: 21590563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncorking the biomanufacturing bottleneck.
    Dove A
    Nat Biotechnol; 2002 Aug; 20(8):777-9. PubMed ID: 12148000
    [No Abstract]   [Full Text] [Related]  

  • 5. Congress works to permit 'biosimilar' drugs very soon.
    Carroll J
    Manag Care; 2009 Apr; 18(4):7-8. PubMed ID: 19472559
    [No Abstract]   [Full Text] [Related]  

  • 6. Recombinant protein therapeutics--success rates, market trends and values to 2010.
    Pavlou AK; Reichert JM
    Nat Biotechnol; 2004 Dec; 22(12):1513-9. PubMed ID: 15583654
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biosimilar products--cheaper version of biological drugs. New possibilities within several therapeutic fields].
    Mellstedt H
    Lakartidningen; 2009 Jun 3-9; 106(23):1563-6. PubMed ID: 19583014
    [No Abstract]   [Full Text] [Related]  

  • 8. Biosimilars--science, status, and strategic perspective.
    Kresse GB
    Eur J Pharm Biopharm; 2009 Aug; 72(3):479-86. PubMed ID: 19286455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amgen's TPO mimic faces stiff competition.
    Lawrence S
    Nat Biotechnol; 2006 Sep; 24(9):1044. PubMed ID: 16964197
    [No Abstract]   [Full Text] [Related]  

  • 10. Small molecules for small minds? The case for biologic pharmaceuticals.
    Projan SJ; Gill D; Lu Z; Herrmann SH
    Expert Opin Biol Ther; 2004 Aug; 4(8):1345-50. PubMed ID: 15268667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharma swept up in biogenerics gold rush.
    Ratner M
    Nat Biotechnol; 2009 Apr; 27(4):299-301. PubMed ID: 19352348
    [No Abstract]   [Full Text] [Related]  

  • 12. Lifecycle management for recombinant protein production using mammalian cell culture technology.
    Moran E; Gammell P
    Adv Biochem Eng Biotechnol; 2014; 139():245-56. PubMed ID: 24196316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Japan-China merger puts growth in East Asia first.
    Sipp D
    Nat Biotechnol; 2005 Aug; 23(8):907. PubMed ID: 16082348
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug industry finds new partners in cost-containment quest.
    J Am Health Policy; 1994; 4(4):64. PubMed ID: 10136688
    [No Abstract]   [Full Text] [Related]  

  • 15. Golden rule of economics yet to strike prospectors.
    Simpson D; Sedjo R
    Nature; 2004 Aug; 430(7001):723. PubMed ID: 15306784
    [No Abstract]   [Full Text] [Related]  

  • 16. Analysis of the economic situation of the South East European pharmaceutical industry.
    Milenković J; Lakić D
    J Med Econ; 2020 Sep; 23(9):932-939. PubMed ID: 32349564
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drugs produced by genetic techniques. Current state and future perspectives--3: Candidates for production].
    Hentze S
    Fortschr Med; 1991 Jan; 109(2):53-4. PubMed ID: 2026369
    [No Abstract]   [Full Text] [Related]  

  • 18. Strategic groups in the biopharmaceutical industry: implications for performance.
    Erden Z; von Krogh G; Nytorp C; Hultberg M
    Drug Discov Today; 2009 Aug; 14(15-16):726-30. PubMed ID: 19416760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese manufacturers vie for piece of outsourcing pie.
    Jia H
    Nat Biotechnol; 2007 Dec; 25(12):1337-8. PubMed ID: 18066012
    [No Abstract]   [Full Text] [Related]  

  • 20. 2013 Statistics for global prescription medications: CNS therapeutics maintain a leading position among small molecule therapeutics.
    Lindsley CW
    ACS Chem Neurosci; 2014 Apr; 5(4):250-1. PubMed ID: 24735159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.